Christian Hampp

Christian Hampp,

Affiliate Faculty

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-6248
Business Email: champp@ufl.edu

Teaching Profile

Courses Taught
2010,2018-2019
PHA6935 Selected Topics in Pharmacy
2012-2015,2018-2019
PHA6891 Introduction to Pharmacoepidemiology

Publications

2023
Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System.
Clinical epidemiology. 15:645-660 [DOI] 10.2147/CLEP.S405165. [PMID] 37274833.
2023
Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy.
Annals of internal medicine. 176(4):443-454 [DOI] 10.7326/M22-1743. [PMID] 36940443.
2022
Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing.
Drug safety. 45(12):1517-1527 [DOI] 10.1007/s40264-022-01244-6. [PMID] 36318419.
2021
Calibration of Chronic Lung Disease Severity as a Risk Factor for Respiratory Syncytial Virus Hospitalization.
Journal of the Pediatric Infectious Diseases Society. 10(3):317-325 [DOI] 10.1093/jpids/piaa107. [PMID] 32978942.
2020
Erratum. Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90-97.
Diabetes care. 43(9) [DOI] 10.2337/dc20-er09a. [PMID] 32647048.
2018
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study.
Diabetes care. 41(1):39-48 [DOI] 10.2337/dc17-0476. [PMID] 29122893.
2017
Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.
Epidemiology (Cambridge, Mass.). 28(6):838-846 [DOI] 10.1097/EDE.0000000000000709. [PMID] 28682851.
2016
Notes from the Field: Pediatric Emergency Department Visits for Buprenorphine/Naloxone Ingestion – United States, 2008-2015.
MMWR. Morbidity and mortality weekly report. 65(41):1148-1149 [DOI] 10.15585/mmwr.mm6541a5. [PMID] 27764078.
2016
Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study.
Annals of internal medicine. 164(11):705-14 [DOI] 10.7326/M15-2568. [PMID] 27110660.
2015
Patient understanding of drug risks: an evaluation of medication guide assessments.
Pharmacoepidemiology and drug safety. 24(5):518-25 [DOI] 10.1002/pds.3762. [PMID] 25808393.
2013
Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study.
JAMA pediatrics. 167(12):1118-24 [DOI] 10.1001/jamapediatrics.2013.2636. [PMID] 24126903.
2013
Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007.
Obstetrics and gynecology. 121(1):106-14 [DOI] http://10.1097/AOG.0b013e318278ce86. [PMID] 23262934.
2012
An algorithm to identify preterm infants in administrative claims data.
Pharmacoepidemiology and drug safety. 21(6):640-50 [DOI] 10.1002/pds.3264. [PMID] 22504840.
2012
Effectiveness of palivizumab prophylaxis in infants and children in Florida.
Pharmacoepidemiology and drug safety. 21(1):53-60 [DOI] 10.1002/pds.2246. [PMID] 21919115.
2012
Feasibility of short-term infusion of magnesium sulfate in pediatric patients with status asthmaticus.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 17(2):150-4 [DOI] 10.5863/1551-6776-17.2.150. [PMID] 23118666.
2012
Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply.
Archives of pediatrics & adolescent medicine. 166(10):968-70 [DOI] 10.1001/archpediatrics.2012.1594. [PMID] 23753905.
2011
Age-Dependent Effectiveness of Rsv Immunoprophylaxis
Pharmacoepidemiology and Drug Safety. 20
2011
Appropriateness of Age Thresholds for Palivizumab Prophylaxis in Preterm Infants
Pharmacoepidemiology and Drug Safety. 20
2011
Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
Pharmacotherapy. 31(6):537-45 [DOI] 10.1592/phco.31.6.537. [PMID] 21923437.
2011
Longitudinal study of optic cup progression in children.
Journal of pediatric ophthalmology and strabismus. 48(3):151-6 [DOI] 10.3928/01913913-20100719-06. [PMID] 20669878.
2011
Review of a large clinical series: once- versus twice-daily enoxaparin for venous thromboembolism prophylaxis in high-risk trauma patients.
Journal of intensive care medicine. 26(2):111-5 [DOI] 10.1177/0885066610384462. [PMID] 21257630.
2010
Comparison of Rsv Seasonality in Four States
American Journal of Epidemiology. 171
2010
Latitude as a Factor in Rsv Epidemiology in Florida
American Journal of Epidemiology. 171
2010
Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida.
The Journal of pediatrics. 156(6):953-959.e1 [DOI] 10.1016/j.jpeds.2009.12.016. [PMID] 20223478.
2010
Root cause analysis and subsequent intervention to improve first dose antibiotic turnaround time for hospitalized pediatric patients.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 15(3):182-8 [PMID] 22477810.
2010
Small budget impact is a result of flawed assumptions and ignores questionable cost-effectiveness for RSV prophylaxis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 13(5) [DOI] 10.1111/j.1524-4733.2010.00723.x. [PMID] 20412545.
2009
Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis With Palivizumab From the Perspective of a Southern Us Medicaid Agency
Value in Health. 12(7):A301-A302 [DOI] 10.1016/S1098-3015(10)74479-X.
2009
Seasonal Versus Needs-Based Immunization Schedules-the Example of Rsv
Value in Health. 12(7) [DOI] 10.1016/S1098-3015(10)74509-5.
2009
Validation of the National Respiratory and Enteric Virus Surveillance System for the Detection of Respiratory Syncytial Virus Seasons
Pharmacoepidemiology and Drug Safety. 18
2008
Cost-utility analysis of rimonabant in the treatment of obesity.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 11(3):389-99 [DOI] 10.1111/j.1524-4733.2007.00281.x. [PMID] 18179661.
2008
Erythropoiesis-Stimulating Agent Exposure and Incidence of Venous Thromboembolism in High-Risk Trauma Patients Receiving Enoxaparin.
Critical Care Medicine. 36
2008
Palivizumab Utilization and Compliance With Recommendations in Florida
Pharmacoepidemiology and Drug Safety. 17
2008
Response to respiratory synctial virus.
Southern medical journal. 101(2):212-3; author reply 213 [DOI] 10.1097/SMJ.0b013e3181611d5f. [PMID] 18364631.
2008
Role of Age in Respiratory Syncycial Virus Infection Risk – Recommendations for Palivizumab Utilization
Pharmacoepidemiology and Drug Safety. 17

Contact Details

Phones:
Business:
(352) 273-6248
Emails:
Business:
champp@ufl.edu
Addresses:
Business Mailing:
PO Box 100496
GAINESVILLE FL 32610
Business Street:
101 NEWELL DR
GAINESVILLE FL 32611